Takashi Nakamura
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 28, 2023
Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease.Megumi Shimizu, Ryo Naito, Akihiro Sato
|May 27, 2023
A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases.Ken Sato, Atsushi Naganuma, Tamon Nagashima
|Jul 12, 2022
The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data.Seigo Akari, Takashi Nakamura, Kenichi Furusawa
|Apr 14, 2021
Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.Takashi Nakamura, Mai Nampei, Takayo Murase
|Mar 17, 2021
GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice.Takashi Nakamura, Hitomi Tanimoto, Masayuki Okamoto
|Jan 15, 2021
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.Takeo Ishii, Tomohiro Kumagae, Hiromichi Wakui
Pageof 2
